{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:09:04Z","timestamp":1762016944507},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1007\/s11102-005-5349-x","type":"journal-article","created":{"date-parts":[[2005,3,2]],"date-time":"2005-03-02T10:28:01Z","timestamp":1109759281000},"page":"83-87","source":"Crossref","is-referenced-by-count":40,"title":["Pituitary Apoplexy During Therapy with Cabergoline in an Adolescent Male with Prolactin-Secreting Macroadenoma"],"prefix":"10.1007","volume":"7","author":[{"given":"Mirta","family":"Knoepfelmacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam C.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenice B.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5349_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0889-8529(18)30167-1","volume":"22","author":"CA Rolih","year":"1993","unstructured":"Rolih CA, Ober KP. Pituitary apoplexy. Endocrinology and Metabolism Clin N Am 1993;22:291\u2013302.","journal-title":"Endocrinology and Metabolism Clin N Am"},{"key":"5349_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2265.1999.00754.x","volume":"51","author":"HS Randeva","year":"1999","unstructured":"Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH. Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol 1999;51:181\u2013188.","journal-title":"Clin Endocrinol"},{"key":"5349_CR3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jnnp.71.4.542","volume":"71","author":"V Biousse","year":"2001","unstructured":"Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neuros and Psych 2001;71:542\u2013545.","journal-title":"J Neurol Neuros and Psych"},{"issue":"2","key":"5349_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/acta.0.0980171","volume":"98","author":"J Yamaji","year":"1981","unstructured":"Yamajix J, Ishibashi M, Kosaka K, Hori T, Manaka S. Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol(Copenh.) 1981;98(2):171\u2013177.","journal-title":"Acta Endocrinol(Copenh.)"},{"key":"5349_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1227\/00006123-198809000-00024","volume":"23","author":"K Shirataki","year":"1988","unstructured":"Shirataki K, Chihara K, Shibata Y, Tamaki N, Matsumoto S, Fujita T. Pituitary apoplexy manifested during a bromocriptine test in a patient with growth hormone and prolactin producing pituitary adenoma. Neurosurgery 1988;23:395\u2013398.","journal-title":"Neurosurgery"},{"key":"5349_CR6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000023199","volume":"50","author":"G Pinto","year":"1998","unstructured":"Pinto G, Zerah M, Trivin C, Brauner R. Pituitary apoplexy in an adolescent with prolactin-secreting adenoma. Hormone Research 1998;50:38\u201341.","journal-title":"Hormone Research"},{"key":"5349_CR7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-100-1-78","volume":"100","author":"ML Vance","year":"1984","unstructured":"Vance ML, Evans W, Thorner M. Bromocriptine Ann Intern Med 1984;100:78\u201391.","journal-title":"Bromocriptine Ann Intern Med"},{"key":"5349_CR8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJM198509123131103","volume":"313","author":"A Liuzzi","year":"1985","unstructured":"Liuzzi A, Dallabonzana D, Oppizzi G, Verde GG, Cozzi R, Chiodini P, Luccarelli G. Low dose of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 1985;313:656\u2013659.","journal-title":"N Engl J Med"},{"key":"5349_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","volume":"60","author":"ME Molitch","year":"1985","unstructured":"Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO. Bromocriptine as primary therapy for prolactin-secreting macroprolactinomas: Result of a prospective multicenter study. J Clin Endocrinol Metab 1985;60:698\u2013705.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR10","first-page":"2338","volume":"81","author":"BMK Biller","year":"1996","unstructured":"Biller BMK, Molitch ME, Vance ML,Cannistraro KB, Davis KR, Simons JA, Schoenfelder JR, Kklibanski A. Treatment of prolactin-secreting macroadenomas with once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 1996;81:2338\u20132343.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.1997.1300952.x","volume":"46","author":"CI Ferrari","year":"1997","unstructured":"Ferrari CI, Abs R, Bevan JS, Brabant G,Ciccarelli E, Motta T, Mucci M, Muratori M, Musatti L, Verbessem G, Scanlon MF. Treatment of macroprolactinomas with cabergoline: A study of 85 patients. Clin Endocrinol (Oxf.) 1997;46:409\u2013415.","journal-title":"Clin Endocrinol (Oxf.)"},{"key":"5349_CR12","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Di Sarno A, Landi ML, Crillo S, Sarnacchiaro F, Facciolli G, Annunziato L, Lombardi G. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 1997;82:3574\u20133579.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR13","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","volume":"84","author":"J Verhelst","year":"1999","unstructured":"Verhelst J, Abs R, Maiter D, Van Den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts, Perossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A. Cabergoline in the tretment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metab 1999;84:2518\u20132522.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR14","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1210\/jcem.83.8.5001","volume":"83","author":"A Colao","year":"1998","unstructured":"Colao A, Loche S, Cappa M, Di Sarno A, Landi ML, Sarnacchiao F, Faccioli G, Lombardi, G. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 1998;83:2777\u20132780.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3171\/jns.1994.80.2.0209","volume":"80","author":"MD Partington","year":"1994","unstructured":"Partington MD, Davis DH, Laws ER Jr, Scheithauer BW. Pituitary adenomas in childhood and adolescence: Results of transsphenoidal surgery. J Neuros 1994;80:209\u2013216.","journal-title":"J Neuros"},{"key":"5349_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/JPEM.1995.8.2.79","volume":"8","author":"T Mindermann","year":"1995","unstructured":"Mindermann T, Wilson CB. Pituitary adenomas in childhood and adolescence. Journal of Pediatric Endocrinology and Metaboslism 1995;8:79\u201383.","journal-title":"Journal of Pediatric Endocrinology and Metaboslism"},{"key":"5349_CR17","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1210\/jcem.84.12.6240","volume":"84","author":"S Knwar","year":"1999","unstructured":"Knwar S, Wilson CB. Pediatric pituitary adenomas. J Clin Endocrinol Metab 1999;84:4385\u20134389.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4065\/73.11.1046","volume":"73","author":"RD Calle-Rodrigue","year":"1998","unstructured":"Calle-Rodrigue RD, Gianni C, Scherthauer BW, Lloyd RV, Wollan PC, Kovacs KT, Stefaneanu L, Ebright AB, Abboud CF, Davis DH. Prolactinomas in male and female patients: A comparative clinical pathologic study. Mayo Clinic Proc 1998;73:1046\u20131052.","journal-title":"Mayo Clinic Proc"},{"issue":"1","key":"5349_CR19","first-page":"7","volume":"23","author":"E Delgrange","year":"1998","unstructured":"Delgrange E, Maiter D, Donckier J, Tourniare J. Influence of age on the clinical presentations of prolactinomas in male. Min Endocrinol 1998;23(1):7\u201316.","journal-title":"Min Endocrinol"},{"key":"5349_CR20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archpedi.1993.02160340043011","volume":"147","author":"D Tyson","year":"1993","unstructured":"Tyson D, Reggiardo D, David R. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy. Am J Dis Child 1993;147:1057\u20131061.","journal-title":"Am J Dis Child"},{"key":"5349_CR21","first-page":"2102","volume":"82","author":"E Delgrange","year":"1997","unstructured":"Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J. Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102\u20132107.","journal-title":"J Clin Endocrinol Metab"},{"key":"5349_CR22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3171\/jns.1998.89.6.1043","volume":"89","author":"PC Albuquerque","year":"1998","unstructured":"Albuquerque PC, Hinton DR, Weiss MH. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma: Case report. J Neuros 1998;89:1043\u20131046.","journal-title":"J Neuros"},{"key":"5349_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3171\/jns.1981.55.2.0187","volume":"55","author":"S Wakai","year":"1981","unstructured":"Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: Its incidence and clinical significance. J Neuros 1981;55:187\u2013193.","journal-title":"J Neuros"},{"key":"5349_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0090-3019(82)90388-3","volume":"18","author":"G Mohr","year":"1982","unstructured":"Mohr G, Hardy J. Haemorrhage, necrosis and apoplexy in pituitary adenomas. Surg Neurol 1982;18:181\u2013189.","journal-title":"Surg Neurol"},{"issue":"3","key":"5349_CR25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1590\/S0004-282X1998000300015","volume":"56","author":"M Miranda","year":"1998","unstructured":"Miranda M, Barros L, Knoepfelmacher M, Augusto E, Jacomosi A, Cukiert A, Salgado LR, Goldman J, Liberman B. Pituitary apoplexy followed by endocrine remission. Report of two cases. Arqu Neuro-Psiq 1998;56(3):449\u2013452.","journal-title":"Arqu Neuro-Psiq"},{"key":"5349_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00019616-200109000-00012","volume":"11","author":"M Knoepfelmacher","year":"2001","unstructured":"Knoepfelmacher M, Ursich M, Barros LM, Duarte A, Salgado LR, Pimentel-Filho FB, Liberman B. Insulin resistance associated to high levels of TNF during pituitary apoplexy induced by a pituitary stimulating test in an acromegalic patient. The Endocrinologist 2001;11:425\u2013428.","journal-title":"The Endocrinologist"},{"key":"5349_CR27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1227\/00006123-198403000-00021","volume":"14","author":"ER Cardoso","year":"1984","unstructured":"Cardoso ER, Peterson EW. Pituitary apoplexy: A review. Neurosurgery 1984;14:363\u2013373.","journal-title":"Neurosurgery"},{"key":"5349_CR28","first-page":"2247","volume":"87","author":"A Colao","year":"2000","unstructured":"Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G. Macroprolactinoma Shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: A prospective study in 110 patients. J Clin Endocrinol Metab 2000;87:2247-2252.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-005-5349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-005-5349-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-005-5349-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T10:13:21Z","timestamp":1559556801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-005-5349-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["5349"],"URL":"https:\/\/doi.org\/10.1007\/s11102-005-5349-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}